Quantcast

Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:
Welcome, Guest. Please login or register.
September 15, 2014, 09:46:44 PM

Login with username, password and session length


Members
Stats
  • Total Posts: 638882
  • Total Topics: 48501
  • Online Today: 282
  • Online Ever: 585
  • (January 07, 2014, 02:31:47 PM)
Users Online

Welcome


Welcome to the POZ/AIDSmeds Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and others concerned about HIV/AIDS.  Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the conversation yourself by registering on the left side of this page.

Privacy Warning:  Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.

  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

  • Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators of these forums. Click here for “Am I Infected?” posting guidelines. Click here for posting guidelines pertaining to all other POZ/AIDSmeds community forums.

  • We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are true and correct to their knowledge.

  • Product advertisement—including links; banners; editorial content; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from POZ.

To change forums navigation language settings, click here (members only), Register now

Para cambiar sus preferencias de los foros en español, haz clic aquí (sólo miembros), Regístrate ahora

Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: North America vs Africa Drug Adherence Review  (Read 1290 times)

0 Members and 1 Guest are viewing this topic.

Offline DanielMark

  • Member
  • Posts: 1,475
North America vs Africa Drug Adherence Review
« on: August 09, 2006, 05:55:32 AM »
'Mistake' to think poverty alone leads to missed anti-HIV drugs
Tue, 08 Aug 2006
CBC News


Surprisingly, a higher proportion of HIV patients in sub-Saharan Africa are following instructions when taking anti-HIV medications compared with those in North America, a new review says.

Antiretroviral therapy or ART has improved the lives of people infected with HIV. To reliably suppress the virus and prevent resistance, people may need to follow a complicated regimen with varying doses and dietary restrictions — all while dealing with a host of unpleasant side-effects of the medication.

There were concerns among medical authorities that poor African patients without formal education might not follow the regimen properly.

"This review contradicts a historical anticipation of poor adherence by Africans to antiretroviral regimens that was offered as a rationale to delay providing these therapies," said the study's lead author, Edward Mills, director of the Centre for International Health and Human Rights Studies in Toronto.

Mills and his colleagues looked at data involving about 17,000 HIV-infected patients in North America and about 12,000 in sub-Saharan Africa.

The study found that about 60 per cent of North Americans took their medications as directed, compared to slightly more than 75 per cent among sub-Saharan Africans, the team reports in Wednesday's issue of the Journal of the American Medical Association.


Access to affordable medications

In North America, barriers to following treatment regimes appear to include poor relationships between doctors and patients, untreated depression, and substance abuse, rather than poverty itself.

"Thinking that poverty was a risk factor for non-adherence was a mistake," said senior author Dr. David Bangsberg of San Francisco General Hospital Medical Center.

For Africa, the priority should be on ensuring patients take their medication by increasing access to affordable drugs, and distributing it to patients, the study's authors said.

Officials with the World Health Organization aim to increase access to antiretrovirals in sub-Saharan Africa. In Botswana for example, an estimated 56 per cent of HIV/AIDS patients urgently need therapy.

"Missed doses among the poor in resource-limited settings is less about neglected doses due to complex behavioural and social problems and is more about structural barriers to reliable medication access," Bangsberg said.

The study's authors note the complexity of the treatment regimen is potentially greater in North America, which should be taken into consideration when interpreting the data.

The research received funding from the Ontario and federal governments, as well as the National Institutes of Health in the U.S., and the Doris Duke Charitable Foundation.
MEDS: REYATAZ & KIVEXA (SINCE AUG 2008)

MAY 2000 LAB RESULTS: CD4 678
VL STILL UNDETECTABLE

DIAGNOSED IN 1988

Offline Cliff

  • Member
  • Posts: 2,645
Re: North America vs Africa Drug Adherence Review
« Reply #1 on: August 09, 2006, 12:34:09 PM »
This is nonesense.  Why would anyone assume that just because someone is poor or live in Africa that they aren't smart enough to figure out when to take a couple of pills a day, in the first place?  Give people some credit for having a brain.  People aren't dying in Africa because they can't take their meds on time, they're dying because they don't have access to meds.  Study that.

Offline DanielMark

  • Member
  • Posts: 1,475
Re: North America vs Africa Drug Adherence Review
« Reply #2 on: August 09, 2006, 02:32:28 PM »
Agreed.

Like the article said:

"Missed doses among the poor in resource-limited settings is less about neglected doses due to complex behavioural and social problems and is more about structural barriers to reliable medication access," Bangsberg said.


Daniel
MEDS: REYATAZ & KIVEXA (SINCE AUG 2008)

MAY 2000 LAB RESULTS: CD4 678
VL STILL UNDETECTABLE

DIAGNOSED IN 1988

Offline blondbeauty

  • Member
  • Posts: 1,784
Re: North America vs Africa Drug Adherence Review
« Reply #3 on: August 09, 2006, 06:41:04 PM »
A few days ago I saw a document on TV about that. It was incredible. There was an old grandmother looking after her 5 year old granddaughter because her parents had died from aids. She lived in a mud hut and a nurse wanted to supervise her while she prepared the meds for her child. It was amazing how she measured the exact amount of water using a stringer, dissolved the meds and gave them to the very obedient child. The girl was doing really well.
So even she didnīt know to read and write and had never been in contact with our "civilization" she did a great job!
The only member in these forums approved by WINBA: World International Nail and Beauty Association.
Epstein Barr +; CMV +; Toxoplasmosis +; HIV-1 +.
Counts when starting treatment:
V.L.:80.200 copies. CD4: 25%=503
Started Sustiva-Truvada 14/August/2006
Last V.L.count (Oct 2013): Undetectable
Last CD4 count (OCT 2013): 52%= 933

Offline Eldon

  • Member
  • Posts: 2,664
Re: North America vs Africa Drug Adherence Review
« Reply #4 on: August 09, 2006, 10:27:37 PM »
Hello Dainel, it is Eldon. I do agree with the article. However, I am in agreement with Cliff; the HIV/AIDS cases over in Africa just don't have the access to the medications like we do. This is why they are dying.

 


Terms of Membership for these forums
 

© 2014 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.